BackSartorius Stedim Biotech S.A. Overview

Sartorius Stedim Biotech S.A. Current Cash

Sartorius Stedim Biotech S.A.'s current cash is $200M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$203.90M
↓ 70.84% YoYΔ $-495.40M vs prior year quarter

Peer trimmed avg / median

Loading

Sartorius Stedim Biotech S.A. Current Cash History

Loading

Sartorius Stedim Biotech S.A. vs. peers: Current Cash Comparison

Loading

Sartorius Stedim Biotech S.A. Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sartorius Stedim Biotech S.A. (SDMHF) FAQ

As of the most recent data (June 2026), SDMHF shows a current cash of $200M. That compares with $700M in the prior-year period — down 70.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SDMHF's current cash is now $200M (was $700M) — a 70.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Sartorius Stedim Biotech S.A. is outperforming or lagging.

Tracking SDMHF's current cash over time shows whether Sartorius Stedim Biotech S.A. is scaling, shrinking, or reshaping that part of the business. The current reading is $200M That compares with $700M in the prior-year period — down 70.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Sartorius Stedim Biotech S.A.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $200M) with ownership activity and broader fundamentals.